Assyro AI

Orange Book product · Generic (ANDA)

ATORVASTATIN CALCIUM

ATORVASTATIN CALCIUM

Generic (ANDA)ANDA 214513TE ABRX LAURUS
View ATORVASTATIN CALCIUM familyOpen on FDA Orange Book

At a glance

Jan 22, 2024

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 22, 2024

    2 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ATORVASTATIN CALCIUM

Strength

EQ 10MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 214513

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ATORVASTATIN CALCIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo